These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33603784)

  • 21. Integrative Analysis Identified a 6-miRNA Prognostic Signature in Nasopharyngeal Carcinoma.
    Chen Y; Wang Z; Li H; Li Y
    Front Cell Dev Biol; 2021; 9():661105. PubMed ID: 34336826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
    Zhao X; Cui L
    J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
    Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
    PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
    Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action.
    Yang X; Pang YY; He RQ; Lin P; Cen JM; Yang H; Ma J; Chen G
    FEBS Open Bio; 2018 Jan; 8(1):64-84. PubMed ID: 29321958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small RNA sequencing identified miR-3180 as a potential prognostic biomarker for Chinese hepatocellular carcinoma patients.
    Sun L; Zhou H; Zhao X; Zhang H; Wang Y; Li G
    Front Genet; 2023; 14():1102171. PubMed ID: 37051592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
    Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
    World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
    Wang G; Dong F; Xu Z; Sharma S; Hu X; Chen D; Zhang L; Zhang J; Dong Q
    BMC Cancer; 2017 Dec; 17(1):805. PubMed ID: 29191172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
    Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
    Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
    Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL
    Front Oncol; 2020; 10():780. PubMed ID: 32587825
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

  • 35. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.
    Fang F; Song T; Zhang T; Cui Y; Zhang G; Xiong Q
    Oncotarget; 2017 May; 8(19):31745-31757. PubMed ID: 28423650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma.
    Song ZB; Yu Y; Zhang GP; Li SQ
    Front Cell Dev Biol; 2021; 9():728574. PubMed ID: 34676211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-Regulation of hsa-miR-210 Promotes Venous Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma.
    Ji J; Rong Y; Luo CL; Li S; Jiang X; Weng H; Chen H; Zhang WW; Xie W; Wang FB
    Front Oncol; 2018; 8():569. PubMed ID: 30560088
    [No Abstract]   [Full Text] [Related]  

  • 39. A seven-miRNA expression-based prognostic signature and its corresponding potential competing endogenous RNA network in early pancreatic cancer.
    Bai X; Lu D; Lin Y; Lv Y; He L
    Exp Ther Med; 2019 Sep; 18(3):1601-1608. PubMed ID: 31410115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Four Oxidative Stress-Responsive MicroRNAs, miR-34a-5p, miR-1915-3p, miR-638, and miR-150-3p, in Hepatocellular Carcinoma.
    Wan Y; Cui R; Gu J; Zhang X; Xiang X; Liu C; Qu K; Lin T
    Oxid Med Cell Longev; 2017; 2017():5189138. PubMed ID: 28811864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.